NewTimeSpace News: The listing application of Hangzhou Bangshun Pharmaceutical Co., Ltd. submitted to HKEX on 22 January 2026 has lapsed upon expiry of the six-month validity period. China Securities International served as the original sole sponsor. The Company is a biotech firm nearing commercialisation, focusing on oncology and autoimmune diseases. Its core asset Bezacitinib is expected to become one of the first three domestically developed JAK inhibitors approved in China, ranking No.1 in clinical progress nationwide for the indication of polycythemia vera.
NewTimeSpace News: The listing application of Shanghai A&I Co., Ltd. submitted to HKEX on 22 January 2026 has lapsed upon the expiry of the six-month validity period. Orient Securities International acted as the original sole sponsor. The Company is a leading provider of integrated intelligent manufacturing system solutions in China. By integrating artificial intelligence technology and manufacturing engineering capabilities, it delivers one-stop intelligent solutions covering automotive, communications, robotics, new energy and other sectors. According to Frost & Sullivan, based on 2024 revenue, the Company ranks No.1 in China for automotive driveshaft equipment, top four for brake-by-wire equipment and automotive differential equipment, and top seven for communication base station thermal modules.
NewTimeSpace News: ZHONGJI INNOLIGHT (03308.HK) launches its public offering on 22 July. Each board lot comprises 50 shares with an entry cost of approximately HK$51,009. The Company proposes a global offering of 54.5 million H Shares at a maximum offer price of HK$1,010 per share, with listing scheduled for 30 July. Cornerstone investors commit approximately US$3.45 billion (around HK$27.04 billion). Based on the maximum offer price, they will subscribe for roughly 26.7722 million H Shares, representing 49.12% of the global offering H Shares.
NewTimeSpace News: Silicon-Magic Semiconductor Technology (Hangzhou) Co., Ltd. refiled its listing application with HKEX for the third time on 20 July, with Huatai International acting as sole sponsor. A power semiconductor player adopting the Virtual IDM model, the Company delivers high-efficiency power management solutions via proprietary process technologies. Its product portfolio covers mobile, display and power device segments, widely deployed in automotive, data center (including AI servers), industrial and consumer electronics applications.
NewTimeSpace News: TOPSTAR refiled its listing application with HKEX on 20 July, with Huatai International acting as sole sponsor. Per Frost & Sullivan data, the Group has developed mainland China’s first intelligent humanoid robot deployed in injection molding scenarios and been designated as the Chain Leader Enterprise of Guangdong’s intelligent robot industrial chain by Guangdong authorities.
NewTimeSpace News: The HKEX listing application of Beijing DELTAPHONE TECHNOLOGY CO., LIMITED, filed on 20 January 2026, has expired upon the end of the six-month validity term, with SUNNY FORTUNE as the original sole sponsor. According to Frost & Sullivan, ranked by FY2024 revenue, the Group is China’s fifth-largest independent professional AIoT service provider with a market share of around 1.8%, and the third-largest independent professional AIoT service provider serving China’s energy sector with a market share of roughly 9.9%.
NewTimeSpace News: The HKEX listing application of Shenzhen WOKE TECHNOLOGY Co., Ltd., filed on 20 January 2026, has expired upon the lapse of the 6-month validity period. Huatai International acted as the original sole sponsor. As a Southeast Asia-focused cross-border new retail operator empowered by full-link digital capabilities, it is the top Chinese cross-border player in Indonesia’s 3C accessories segment by retail sales value in 2024.
NewTimeSpace News: ZHONGJI INNOLIGHT has obtained an overseas listing filing notice issued by the CSRC. The Company plans to issue no more than 94,004,350 overseas-listed ordinary shares for listing on the Main Board of HKEX.
NewTimeSpace News: YUEN KEE DUMPLING has obtained filing approval from CSRC for its overseas listing and full circulation of domestic unlisted shares. The Group plans to issue a maximum of 23.824 million H Shares, while 20 shareholders intend to convert 82.316 million domestic shares to H Shares. The filing is valid for 12 months. CSRC does not provide substantive judgment or guarantee on the investment value of the enterprise.
NewTimeSpace News: RELYEZ has obtained filing approval from CSRC for overseas listing. The Company proposes to issue no more than approximately 135 million H Shares for listing on HKEX Main Board. Meanwhile, domestic unlisted shares totalling 352 million held by 13 shareholders will be converted into H Shares for full circulation.
NewTimeSpace News: AULTON refiled its listing application with HKEX on 19 July, with CMB International Capital acting as sole sponsor. Per CIC data, the Group ranked third in China by revenue generated from battery swapping station operation services in 2025. As at 30 April 2026, a total of 531 battery swapping stations have been connected to its smart energy service platform.
NewTimeSpace News: JPJ (TCM) submitted HKEX listing application on 17 July, with Quam Capital Corporate Finance acting as sole sponsor. According to Frost & Sullivan, the Group ranked first in Hong Kong proprietary Chinese medicine market by 2025 terminal sales with a 9.2% market share. It owns century-old classic brands including 130-year-old Po Chai Pills and over 120-year-old Tin Hee Tong Tin Hee Pills.
NewTimeSpace News: Zhongji Innolight Co., Ltd. passed the HKEX listing hearing on 17 July. Goldman Sachs, CICC, Morgan Stanley and GF Securities act as joint sponsors. Per CIC data, the Company has been the world’s largest optical interconnect solution provider by revenue since 2021, capturing a 21.2% share of the global total market and 28.1% of the high-speed data communication optical interconnect market in 2025.
NewTimeSpace News: Immvira Bioscience Inc. refiled its listing application with HKEX on 16 July, with Citi and CICC acting as joint sponsors. Founded in 2015, the biotech firm focuses on R&D of oncolytic immunotherapies and engineered exosome therapeutics. Its core asset MVR-T3011, a novel HSV-1-based oncolytic immunotherapy in Phase II development, covers full-spectrum bladder cancer and head and neck squamous cell carcinoma among other indications.
NewTimeSpace News: The Hong Kong listing application of Guangdong Topstar Technology Co., Ltd., filed on 16 January 2026, has lapsed upon expiry of the six-month validity period. Huatai International acted as the original sole sponsor. According to Frost & Sullivan, measured by shipment volume of light-load industrial robots and industrial robots deployed in light industries in 2024, the Company secured the top ranking in Mainland China’s industrial robot solution market.
NewTimeSpace News: The Hong Kong listing application of Onyx International Inc., filed on 16 January 2026, has lapsed upon expiry of the six-month validity period. China Securities International acted as the original sole sponsor. According to Frost & Sullivan, measured by retail revenue in 2024, the Company ranks second globally and first in China as a brand of knowledge-focused productivity tools.
